Introduction/Overview
Ferulic acid ethyl ester (CAS number: 4046-02-0), as an ethyl derivative of Ferulic acid, has attracted widespread attention in the field of natural product pharmacology in recent years due to its excellent biological activity and good pharmacological properties. Ethyl ferulate not only retains various biological activities such as antioxidant and anti-inflammatory properties of ferulic acid, but also enhances its lipid solubility and bioavailability through esterification modification, further enhancing its pharmacological effects. Especially in the areas of antiplatelet aggregation and prevention and treatment of cardiovascular diseases, ethyl ferulate has shown significant potential and has become one of the hot molecules in the development of cardiovascular drugs.
This review aims to systematically summarize the chemical structure and physicochemical properties, plant sources, and extraction methods of ethyl ferulate, with a focus on its pharmacological activity and mechanism of action. It delves into its molecular targets and pharmacological evaluation, and combines the latest pharmacokinetic data to comprehensively review its clinical application prospects and development trends, providing theoretical basis and reference for subsequent basic research and drug development.
Chemical structure and physicochemical properties
The molecular formula of ethyl ferulate is C11H14O4, with a molecular weight of 222.24. Structurally, the carboxyl group of ferulic acid forms an ethyl ester bond with ethanol through esterification reaction. Its structural features include a benzene ring with methoxy and hydroxyl groups, connected to an unsaturated ethyl acrylate side chain. The specific structural formula is as follows:
- The 3-methoxy (- OCH3) and 4-hydroxy (- OH) groups on the benzene ring endow it with strong free radical scavenging ability.
- Ethylation of carboxyl groups increases the lipophilicity of molecules and enhances cell membrane permeability.
In terms of physicochemical properties, the LogP value of ethyl ferulate is 2.4956, indicating that it has moderate hydrophobicity and is conducive to transmembrane absorption. The topological polar surface area (TPSA) is 55.76 Å ², which is within the ideal range for drug molecules to pass through the cell membrane. The water solubility is 0.3711 mg/mL, indicating low water solubility but sufficient to meet certain bioavailability requirements. It is worth noting that ethyl ferulate has a high blood-brain barrier (BBB) permeability, indicating its potential application value in central nervous system diseases. In addition, the hERG channel inhibition experiment showed a negative result, indicating a low risk of cardiac toxicity; The Ames mutagenicity test result is 0.0, indicating extremely low genetic toxicity risk and good safety.
Plant sources and extraction methods
Ethyl ferulate is mainly present in various plants, especially in grasses, certain traditional Chinese medicinal herbs, and the outer layer of grains. Typical natural sources include:
- The bran and seed coat of grains such as rice, wheat, and corn.
- Chinese medicinal herbs such as Angelica sinensis and Chuanxiong contain abundant ferulic acid and its derivatives.
- The bark and leaves of certain woody plants.
Traditional extraction methods often use organic solvent extraction and ultrasound assisted extraction techniques, combined with liquid-liquid separation and chromatographic purification steps to obtain high-purity ethyl ferulate. The specific steps are as follows:
- Solvent selection Ethanol, methanol, and their aqueous solutions are commonly used as extraction solvents, and ethanol is widely used due to its safety and extraction efficiency.
- extraction process The use of ultrasound assisted extraction (UAE) or microwave-assisted extraction (MAE) techniques can significantly improve the extraction rate and shorten the time.
- Purification and Separation Purification of ethyl ferulate was carried out using methods such as silica gel column chromatography and high-performance liquid chromatography (HPLC) to ensure its purity and activity.
- Synthesis preparation To meet the large-scale demand, chemical synthesis methods have also been developed, mainly prepared by esterification reaction of ferulic acid and ethanol in the presence of acidic catalysts.
With the advancement of green chemistry and sustainable development, environmentally friendly extraction technologies such as supercritical CO2 extraction are gradually being applied to the extraction research of ethyl ferulate.
Pharmacological activity research
Ethyl ferulate has a wide range of pharmacological activities, including antioxidant, anti-inflammatory, antiplatelet aggregation, neuroprotective, and anti-tumor effects. The following focuses on the research progress of its application in antiplatelet aggregation and related cardiovascular protection.
Antiplatelet aggregation
Platelet aggregation is a crucial step in thrombus formation, directly related to the occurrence of cardiovascular and cerebrovascular diseases such as myocardial infarction and stroke. Ethyl ferulate exhibits significant anti platelet aggregation activity through multi-target regulation of platelet function.
- in vitro experiment Ethyl ferulate can significantly inhibit ADP, collagen, and serotonin induced platelet aggregation and reduce the expression of platelet surface activation markers.
- In vivo model In a rat arterial thrombosis model, ethyl ferulate prolongs blood clotting time, reduces thrombus formation rate, and demonstrates good antithrombotic effects.
- Antioxidant effect By clearing reactive oxygen species (ROS) from platelets, reducing oxidative stress, and protecting platelet function stability.
Other pharmacological activities
- Antioxidant and anti-inflammatory properties Ethyl ferulate can effectively eliminate free radicals, inhibit the release of inflammatory mediators, and reduce tissue damage.
- neuroprotection Due to its excellent blood-brain barrier penetration, it exhibits a protective effect on nerve cells and slows down the progression of neurodegenerative diseases.
- antitumor Some studies suggest that it has potential anti-tumor activity by regulating cell apoptosis and proliferation signaling pathways.
Mechanism of action and molecular targets
The antiplatelet aggregation effect of ethyl ferulate depends on its regulation of multiple key targets, including platelet activation, signal transduction, and thrombus formation processes.
Main target analysis
- PTGS1 (COX-1) and PTGS2 (COX-2)Ethyl ferulate inhibits cyclooxygenase activity, reduces the synthesis of prostaglandin H2 (PGH2) and thromboxane A2 (TXA2) in platelets, and decreases platelet activation and aggregation.
- ITGA2B (integrin α IIb) and ITGB3 (integrin β 3)Regulating the activity of integrin α IIb β 3 complex on the surface of platelets, blocking the binding of fibrinogen to platelets, and inhibiting platelet cross-linking.
- P2RY12 (P2Y12 receptor)As a key receptor for ADP mediated platelet activation, ethyl ferulate blocks ADP induced platelet aggregation by antagonizing the P2Y12 receptor.
- TBXA2R (thromboxane A2 receptor)Inhibit the TXA2 receptor mediated platelet activation signal and reduce the increase in calcium ion concentration in platelets.
- PDE3A (phosphodiesterase 3A)By inhibiting PDE3A activity, increasing platelet cAMP levels, and inhibiting platelet activation.
- GP1BA (glycoprotein Ib α)Regulating the binding of platelets to collagen and von Willebrand factor (vWF) exposed to vascular endothelium, affecting platelet initial adhesion.
Signal pathway regulation
Ethyl ferulate regulates platelet Ca ² ⁺ signaling, cAMP/cGMP pathway, and redox status through multi-target synergistic effects, comprehensively inhibiting platelet activation and aggregation processes. In addition, its antioxidant effect reduces ROS mediated platelet overactivation, further enhancing its antithrombotic effect.
Evaluation of drug properties and pharmacokinetics
Analysis of drug properties parameters
The molecular weight of ethyl ferulate (222.24) conforms to Lipinski's rule, and the LogP value (2.4956) is moderate, indicating its good membrane permeability and oral absorption potential. The TPSA (55.76 Å ²) is below 140 Å ², supporting its excellent cell membrane permeability and blood-brain barrier permeability. Although the water solubility is relatively low (0.3711 mg/mL), solubility limitations can be overcome through rational formulation design.
In terms of safety, negative hERG channel inhibition reduced the risk of cardiac toxicity, and the Ames test result showed 0 with no significant mutagenicity, supporting its good safety foundation.
Pharmacokinetic characteristics
At present, pharmacokinetic studies of ethyl ferulate are still in the preliminary stage, but existing data indicate that:
- Oral absorption is good, and the bioavailability is improved compared to ferulic acid.
- Widely distributed in the body, especially enriched in the heart and brain tissues, which conforms to its high permeability characteristics of the blood-brain barrier.
- Metabolism is mainly achieved through hepatic esterase hydrolysis into ferulic acid and ethanol, and ferulic acid is further metabolized through glucuronidation and sulfation.
- The main excretion pathways are urine and bile excretion.
Further systematic pharmacokinetic and toxicological studies are needed in the future to clarify its in vivo metabolic parameters and long-term safety.
Clinical application prospects and prospects
Ethyl ferulate has broad clinical application prospects, especially in the prevention and treatment of cardiovascular and cerebrovascular diseases, due to its multi-target antiplatelet aggregation effect and good pharmacological safety.
Prevention and treatment of cardiovascular and cerebrovascular diseases
As a natural antiplatelet drug candidate, ethyl ferulate can effectively prevent thrombosis caused by atherosclerotic plaque rupture and reduce the incidence of myocardial infarction, stroke and other thrombosis related diseases. Its blood-brain barrier permeability also provides the possibility for adjuvant therapy of cerebral thrombosis and ischemic stroke.
Neurodegenerative diseases
Due to its antioxidant and neuroprotective effects, ethyl ferulate has gradually gained attention in the treatment research of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, and is expected to become a multi-target neuroprotective drug in the future.
Drug Development and Formulation Innovation
The development of new dosage forms such as nanocarriers, liposomes, and solid dispersions will be key to enhancing the clinical application value of ethyl ferulate due to its low water solubility and metabolic characteristics. In addition, structural modification and derivative design will also promote the optimization of its pharmacological and pharmacokinetic properties.
Challenges and Future Directions
Although ethyl ferulate has shown promising pharmacological potential, its clinical translation still faces several challenges:
- Lack of systematic clinical trial data to validate its safety and effectiveness.
- It is necessary to conduct in-depth analysis of its metabolic pathways and the activity of potential metabolites in the body.
- We need to optimize the formulation process to improve bioavailability and drug stability.
Future research should focus on multi center clinical trial design, in-depth elucidation of molecular mechanisms, and development of new dosage forms to promote the transition of ethyl ferulate from laboratory to clinical applications.
Conclusion
Ethyl ferulate, as a natural derivative, exhibits a wide range of pharmacological activities and good drug properties due to its unique chemical structure and multi-target antiplatelet aggregation effect. Its potential in the prevention and treatment of cardiovascular and cerebrovascular diseases, as well as neuroprotection, is increasingly prominent, becoming one of the important directions for the research and development of natural medicines. Although challenges in pharmacokinetics and clinical validation still need to be overcome, with further research and technological advancements, ethyl ferulate is expected to become a new generation of safe and effective antithrombotic and cardiovascular protective drugs. Future research should strengthen its mechanism analysis, dosage form innovation, and clinical translation, providing a solid theoretical and practical foundation for natural product pharmacology and modern medicine.
